In Vivo T-Cell Depletion (TCD) Does Not Improve Rates of Graft-Versus-Host Disease (GVHD) and Transplantation Outcomes in Patients Undergoing Peripheral Blood Allogeneic Hematopoietic Cell Transplant (AHCT)

A.S. Kanate, S. Osman, A. Cumpston, G. Hobbs, S. Leadmon, P. Bunner, L. Gibson, W. Tse, J. Abraham, S. Remick, M. Craig, M. Hamadani
2011 Biology of Blood and Marrow Transplantation  
than 1000/microlitter following conditioning. Considering platelets, 157 and 12 of patients did not have platelet count less than 20,000 and 100,000/mcrolitter after transplantation respectively. There was no difference for engraftement days between ABO mismatched and matched group. The median RBC transfusion requirement was 7 units prior to 100 days post-HCT and 8 units through one year post-HCT and overall follow-up across all recipients.
doi:10.1016/j.bbmt.2010.12.465 fatcat:usfzktwxejdjnpa7gs4xteaysy